Affordable Access

deepdyve-link
Publisher Website

The Antipsychotic Medication Management Fidelity Scale: Psychometric properties.

Authors
  • Ruud, Torleif1, 2
  • Drivenes, Karin3, 4
  • Drake, Robert E5
  • Haaland, Vegard Øksendal6, 7
  • Landers, Matthew8
  • Stensrud, Bjørn9, 10
  • Heiervang, Kristin S11
  • Tanum, Lars11, 12
  • Bond, Gary R5
  • 1 Division of Mental Health Services, Akershus University Hospital, Lørenskog, Norway. [email protected] , (Norway)
  • 2 Institute of Clincial Medicine, University of Oslo, Oslo, Norway. [email protected] , (Norway)
  • 3 Division of Mental Health, Sørlandet Hospital, Kristiansand, Norway. , (Norway)
  • 4 South Eastern Norway Hospital Pharmacy Enterprise, Kristiansand, Norway. , (Norway)
  • 5 Westat, Lebanon, NH, USA. , (Lebanon)
  • 6 Sørlandet Hospital, Kristiansand, Norway. , (Norway)
  • 7 Clinical Neuroscience Research Group, Department of Psychology, The Faculty of Social Sciences, University of Oslo, Oslo, Norway. , (Norway)
  • 8 Duke University, Durham, NC, USA.
  • 9 Division of Mental Health, Innlandet Hospital Trust, Brumunddal, Norway. , (Norway)
  • 10 National Advisory Unit on Concurrent Substance Abuse and Mental Health Disorders, Brumunddal, Norway. , (Norway)
  • 11 Division of Mental Health Services, Akershus University Hospital, Lørenskog, Norway. , (Norway)
  • 12 Oslo Metropolitan University, Oslo, Norway. , (Norway)
Type
Published Article
Journal
Administration and policy in mental health
Publication Date
Nov 01, 2020
Volume
47
Issue
6
Pages
911–919
Identifiers
DOI: 10.1007/s10488-020-01018-1
PMID: 32030595
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

The paper describes the Antipsychotic Medication Management Fidelity Scale and its psychometric properties, including interrater reliability, frequency distribution, sensitivity to change and feasibility. Fidelity assessors conducted fidelity reviews four times over 18 months at eight sites receiving implementation support for evidence-based antipsychotic medication management. Data analyses shows good to fair interrater reliability, adequate sensitivity to change over time and good feasibility. At 18 months, item ratings varied from poor to full fidelity on most items. Use of the scale can assess fidelity to evidence-based guidelines for antipsychotic medication management and guide efforts to improve practice. Further research should improve and better calibrate some items, and improve the procedures for access to information.Trial registration: ClinicalTrials.gov Identifier: NCT03271242.

Report this publication

Statistics

Seen <100 times